Seborrheic dermatitis is a chronic inflammatory skin disorder characterized by fine scaling and erythema mostly confined to areas where sebaceous glands are prominent.
Pityrosporum ovale infection is common in seborrheic dermatitis.
The characteristic pattern is based on age group.
In infants it appears as cradle cap. It is a diffuse or focal scaling and crusting on the vertex of the scalp that sometimes accompanied by inflammation.
In young children, there is Tinea amiantacea which is one or several patches of dense, plate-like scales, 2-10 cm in size that appear anywhere on the scalp.
While adolescents have dandruff which are fine, dry, white, non-inflammatory scalp scaling with minor itching.

Seborrheic Dermatitis References

  1. Cohen S. Should we treat infantile seborrheic dermatitis with topical antifungals or topical steroids?. Arch Dis Childhood. 2004 Mar;89(3):288-289. PMID: 14977719
  2. Arora V, Arora S. Management of infantile seborrheic dermatitis. Am Fam Physician. 2007 Mar;75:807. PMID: 17390592
  3. Gupta AK, Skinner AR. Ciclopirox for the treatment of superficial fungal infections: a review. Int J Dermatol. 2003 Sep;42(Suppl 1):3-9. PMID: 12895181
  4. Gupta AK, Bluhm R, Cooper EA, et al. Seborrheic dermatitis. Dermatol Clin. 2003 Jul;21:401-412. PMID: 12956195
  5. Johnson BA, Nunley JR. Treatment of seborrheic dermatitis. Am Fam Physician. 2000 May;61(9):2703-2714. PMID: 10821151
  6. Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician. 2006 Jul;74(1):125-130. PMID: 16848386
  7. Vena GA, Micali G, Santoianni P, et al. Oral terbinafine in the treatment of multi-site seborrheic dermatitis: a multicenter, double-blind placebo-controlled study. Int J Immunopathol Pharmacol. 2005;18(4):745-753. PMID: 16388724
  8. Morelli JG. Eczematous disorders. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson textbook of Pediatrics. 18th ed. Philadelphia: Saunders, Elsevier; 2007
  9. Seite S, Rougier A. Lipohydroxy acid containing shampoo in the treatment of scalp seborrheic dermatitis. In: Preedy VR. Handbook of hair in health and disease: Wageningen Academic Publishers; 2012:446-476
  10. Robertson DB, Maibach HI. Dermatologic pharmacology. In: Katzung BG. Basic and clinical pharmacology. 8th ed. New York: Lange Medical Books/McGraw-Hill; 2001
  11. Habif TP. Psoriasis and other papulosquamous diseases. Clinical dermatology: A color guide to diagnosis and therapy. 4th ed. Pennsylvania: Mosby, Elsevier; 2004
  12. Shaw JC, Parker F. Psoriasis and other papulosquamous diseases. In: Noble J, Greene HL, Levinson W, et al. Textbook of primary care medicine. 3rd ed. Philadelphia: Mosby, Inc; 2001
  13. MedWorm
  14. MedWorm
  15. MedWorm
  16. Finnish Medical Society Duodecim. Seborrheic dermatitis. National Guideline Clearinghouse. 2007
  17. Finnish Medical Society Duodecim. Seborrheic dermatitis. National Guideline Clearinghouse. http://www. 2007
  18. Goldenberg G. Optimizing treatment approaches in seborrheic dermatitis. J Clin Aesthet Dermatol. 2013 Feb;6(2):44-49. Accessed 26 Sep 2013. PMID: 23441240
  19. Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. The Journal of Clinical and Aesthetic Dermatology. 2011 May;4(5):32-38. PMID: 21607192
  20. Cheong WK, Yeung CK, Torsekar RG, et al. Treatment of seborrheic dermatitis in Asia: a consensus guide. Skin Appendage Disord. 2015 Nov;1:187-196. doi: 10.1159/000444682.
  21. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015 Feb;91(3):185-190. PMID: 25822272
  22. Marcdante KJ, Kliegman RM. Seborrheic dermatitis. In: Marcdante KJ, Kliegman RM. Nelson Essentials of Pediatrics. 7th ed. Philadelphia, PA: Saunders, Elsevier Inc; 2015.
  23. Guiseppe M, Lacarrubba F, Dall'Oglio F, Tedeschi A, Dirschka T. A new proposed severity score for seborrheic dermatitis of the face: SEborrheic Dermatitis Area and Severity Index (SEDASI). J Am Acad Dermatol. 2017 Jun;76(6)(Suppl 1):AB18. doi: 10.1016/j.jaad.2017.04.088.
  24. Patterson JW. The spongiotic reaction pattern. In: Patterson JW. Weedon's Skin Pathology. 4th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2016.
  25. Sasseville D. Seborrheic dermatitis in adolescents and adults. UptoDate. 26 Mar 2020. Accessed 01 Jun 2018.
  26. Sasseville D. Cradle cap and seborrheic dermatitis in infants. UpToDate. Aug 2019.
  27. Sasseville D. Seborrheic dermatitis in adolescents and adults. UpToDate. Nov 2018.
  28. Piquero-Casals J, Hexsel D, Mir-Bonafé JF. Topical non-pharmacological treatment for facial seborrheic dermatitis. Dermatol Ther (Heidelb). 2019 Sep;9:469-477. doi: 10.1007/s13555-019-00319-0. PMID: 31396944
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Audrey Abella, 6 days ago
A pilot telemedicine initiative may be an alternative for facilitating delivery of intravenous iron (IVI) for individuals requiring iron supplementation.